CMS Connect Login:

Login Assistance

DEA and SAMHSA Extend TelePrescribing Flexibilities

On May 3, 2023, the Drug Enforcement Administration (DEA), in conjunction with the Substance Abuse and Mental Health Services Administration (SAMHSA), issued a temporary rule extending the telemedicine waivers of the Ryan Haight Act (RHA) promulgated during the COVID-19 Public Health Emergency (PHE). This is notable as access to care, including mental health and substance abuse treatment, remains a crucial industry focus, especially as the transition to the post-PHE has begun.

The RHA generally requires a practitioner to perform an in-person medical evaluation prior to the prescribing of controlled substances via telemedicine. The DEA waived this requirement for an in-person medical evaluation during the PHE, as long as certain conditions were met. Under the temporary rule, all the telemedicine flexibilities regarding the prescription of controlled substances that were in place during the PHE will remain in place for an additional six months (until November 11, 2023).

Read more here.

Document Actions

Join CMS

Why join?  The Chicago Medical Society offers many benefits, including career placement, advocacy, networking, and member to member collaboration. Click here to explore all the benefits of membership.

CMS Connect

CMS Connect is an exclusive community that allows members to discuss the issues impacting their practices today. Visit CMS Connect today.